CRRX Share Price Performance
CA$3.72
1.71 (85.07%)
23.4% undervalued intrinsic discount
CA$4.86
Fair Value
Price CA$3.72
AnalystConsensusTarget CA$4.86
AnalystLowTarget CA$2.25
Fair ValueCA$4.86
Share Pricen/a
CareRx Corporation Stock Price
- 2 Narratives written by author
- 0 Comments on narratives written by author
- 4 Fair Values set on narratives written by author
CRRX Community Narratives
AN
Fair Value CA$4.86 23.4% undervalued intrinsic discount
Canadian Long Term Care Expansion Will Broaden Market Reach
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AN
Fair Value CA$2.25 65.3% overvalued intrinsic discount
Canadian Healthcare Cost Cuts Will Crush Margins In Future
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Canadian Long Term Care Expansion Will Broaden Market Reach
Key Takeaways Expansion in serviced beds and supportive government policy position CareRx for sustained revenue growth and increased market share in institutional care. Efficiency initiatives and enhanced service offerings are set to improve margins, operational leverage, and long-term customer relationships.Read more
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AN
CA$4.86
23.4% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
5.75% p.a.
Profit Margin
1.46%
Future PE
60.45x
Price in 2028
CA$5.81
Canadian Healthcare Cost Cuts Will Crush Margins In Future
Key Takeaways Government cost containment and demographic trends are pressuring CareRx's margins and threatening to shrink its core market and future revenue stability. Dependence on a few large contracts and slow geographic diversification exposes CareRx to client and regional risks, limiting its growth potential.Read more
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
CA$2.25
65.3% overvalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
3.95% p.a.
Profit Margin
0.16%
Future PE
303.29x
Price in 2028
CA$2.71
Trending Discussion
Recently Updated Narratives
AN
CRRX: Upcoming Share Buybacks Will Support Stronger Future Shareholder Returns
Fair Value: CA$4.86 23.4% undervalued intrinsic discount
3 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Canadian Healthcare Cost Cuts Will Crush Margins In Future
Fair Value: CA$2.25 65.3% overvalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
CareRx Corporation Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- 0.0015
- 29.81%
- 0.025%
- 50.8%
About CRRX
- Founded
- 2001
- Employees
- 1466
- CEO
- WebsiteView website
CareRx Corporation, together with its subsidiaries, provides pharmacy services to senior homes and other congregate care settings in Canada. The company offers medication management, technology, and program services. It serves long-term care homes, retirement homes, assisted living facilities, and group homes. The company was formerly known as Centric Health Corporation and changed its name to CareRx Corporation in June 2020. CareRx Corporation was incorporated in 2001 and is based in Toronto, Canada.
